Global Proton Therapy Market Report and Forecast 2025-2034

Global Proton Therapy Market Outlook

The global proton therapy market size was valued at USD 1314.6 million in 2024, driven by the increasing incidence of cancer across the globe. The market is expected to grow at a CAGR of 12.4% during the forecast period of 2025-2034, with the values likely to rise from USD 1477 million in 2025 to USD 3749.8 million by 2034.

Proton Therapy: Introduction

Proton therapy is a type of radiation therapy that treats cancer with the help of positively charged ions (protons). It may also be used in the treatment of some noncancerous tumours or in conjunction with treatments like chemotherapy or surgery. Proton therapy has garnered high popularity owing to its minimal side effects when compared to conventional methods as doctors have better hold at controlling the site of energy accumulation.

Global Proton Therapy Market Analysis

The rising prevalence of cancer is a major factor leading to proton therapy market demand. While radiation has been a common part of cancer treatment, proton therapy is now gaining popularity owing to its minimal side effects when compared to traditional radiotherapy. It also facilitates the patients to continue with day-to-day lives owing to its painless nature.

The proton therapy market value is also anticipated to grow with increasing encouragement by regulatory authorities like American Society for Radiation Oncology (ASTRO) to apply the therapy on patients. Consequently, new age pharmaceutical companies are now dedicated to use the therapy. In September 2023, Shuttle Pharmaceuticals Holdings, Inc. conveyed their commitment to employ the treatment on patients at the Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fair.

The market is anticipated to grow with the rising set up proton system into the existing infrastructure. In October 2023, Hitachi launched Southeast Asia’s first proton therapy system in National Cancer Centre Singapore (NCCS). This system is equipped with four rotating gantries and a Real-time image Gating system for Proton Therapy (RGPT) to treat tumours in motion due to respiration. It is also enabled with advanced spot scanning technology to precisely irradiate tumors with compound shapes.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Global Proton Therapy Market Segmentation

Market Breakup by Product Type

• Systems 
  • Accelerators 
    • Cyclotrons 
    • Synchrotrons 
  • Beam Delivery 
    • Pencil Beam Scanning 
    • Passive Scattering 
    • Uniform Scanning 
  • Modulators 
  • Others 
• Software 
• Services

Market Breakup by Components

• Proton Accelerator
  • Cyclotrons
  • Synchrotrons
  • Synchrocyclotrons
  • Linacs
  • H-Minus Synchrotrons
  • Separated Sector Cyclotrons
  • Super-Conducting Cyclotrons
  • Fast Cycling Synchrotron
• Beam Delivery System
  • The Passive Scattering Technique
  • Beam Scanning
• Nozzle
  • Pencil Scanning Nozzle
  • Single Scattering
  • Double Scattering
  • Uniform Scanning Nozzle
• Image Viewers
• Beam Transport System
• Patient Positioning System (PPS)

Market Breakup by Type

• Rotating Proton Therapy Systems

• Non-Rotating Proton Therapy Systems

Market Breakup by Set-Up Systems

• Multi-Room Systems

• Single-Room Systems

Market Breakup by Applications

• Treatment Applications
  • Ediatric Cancer
  • Tumours in the Base of the Skull
  • Prostate Cancer
  • Head and Neck Cancer
  • Breast Cancer
  • Lung Cancer
  • Tumours Affecting Spine
  • Eye Melanoma
  • Lymphoma
  • Pituitary Gland Tumours
  • Others
• Research Applications

Market Breakup by End User

• Hospitals

• Ambulatory Surgical Centres

• Cancer Research Institutes

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Proton Therapy Market Overview

The United States alone is expected to record around 1,958,310 new cancer cases in 2023, hence, it is anticipated to hold a major part of the global proton therapy market share in upcoming years. Having a well-structured infrastructure that can easily adopt newer technologies is another essential component of the large market size. The region is experiencing validation from numerous upcoming companies which are willingly adapting to the latest techniques and devising better means of application.

Having several academic and healthcare institutions at home, Europe holds a massive market share as well. With the help of numerous awareness and educational campaigns, there is emphasis on educating the healthcare staff with the technical knowledge of using all the latest technologies.

The Asia Pacific region, on the other hand, is projected to encounter an upswing in the proton therapy market growth in the foreseeable future. With high national and foreign investments, emerging markets like India are continuously improving their research and healthcare infrastructure. Major healthcare companies are also investing in the Asian markets to leverage the easy availability of resources present in the region.

Global Proton Therapy Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Varian Medical Systems, Inc.

• IBA Group

• Hitachi, Ltd.

• Mevion Medical Systems, Inc.

• Sumitomo Heavy Industries, Ltd.

• Optivus Proton Therapy, Inc.

• ProTom International, Inc.

• Advanced Oncotherapy Plc.

• ProNova Solutions, LLC

• Mitsubishi Electric Corporation

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report